v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional paid-in capital
Treasury stock
Accumulated other comprehensive loss
Accumulated deficit
Balance at Dec. 31, 2024 $ (14,169) $ 14 $ 1,305,677 $ (25,097) $ (13,678) $ (1,281,085)
Balance, shares at Dec. 31, 2024   144,129        
Stock-based compensation 22,318   22,318      
Common stock issued for stock option exercises 505   505      
Common stock issued for stock option exercises, shares   150        
Common stock issued for vesting of performance and restricted stock awards, net of shares retained for tax liability (3,416) $ 1 (3,417)      
Common stock issued for vesting of performance and restricted stock awards, net of shares retained for tax liability, shares   2,627        
Purchase of capped calls (42,485)   (42,485)      
Foreign currency translation adjustments 3,215       3,215  
Net loss (51,907)         (51,907)
Balance at Mar. 31, 2025 (85,939) $ 15 1,282,598 (25,097) (10,463) (1,332,992)
Balance, shares at Mar. 31, 2025   146,906        
Balance at Dec. 31, 2024 (14,169) $ 14 1,305,677 (25,097) (13,678) (1,281,085)
Balance, shares at Dec. 31, 2024   144,129        
Purchase of capped calls (42,485)          
Foreign currency translation adjustments 9,423          
Net loss (93,051)          
Balance at Jun. 30, 2025 23,771 $ 15 1,427,244 (25,097) (4,255) (1,374,136)
Balance, shares at Jun. 30, 2025   148,842        
Balance at Mar. 31, 2025 (85,939) $ 15 1,282,598 (25,097) (10,463) (1,332,992)
Balance, shares at Mar. 31, 2025   146,906        
Stock-based compensation 15,624   15,624      
Common stock issued for warrant exercises 52   52      
Common stock issued for warrant exercises, shares   1,139        
Common stock issued for employee stock purchase plan and stock option exercises 2,326   2,326      
Common stock issued for employee stock purchase plan and stock option exercises, shares   323        
Common stock issued for vesting of performance and restricted stock awards, net of shares retained for tax liability (98)   (98)      
Common stock issued for vesting of performance and restricted stock awards, net of shares retained for tax liability, shares   379        
Common stock issued for asset acquisition 1,000   1,000      
Common stock issued for asset acquisition, shares   95        
Warrant modification 2,301   2,301      
Reclassification of equity-based liability 123,441   123,441      
Foreign currency translation adjustments 6,208       6,208  
Net loss (41,144)         (41,144)
Balance at Jun. 30, 2025 23,771 $ 15 1,427,244 (25,097) (4,255) (1,374,136)
Balance, shares at Jun. 30, 2025   148,842        
Balance at Dec. 31, 2025 12,426 $ 15 1,466,377 (25,097) (4,426) (1,424,443)
Balance, shares at Dec. 31, 2025   150,257        
Stock-based compensation 23,659   23,659      
Common stock issued for stock option exercises 97   97      
Common stock issued for stock option exercises, shares   245        
Common stock issued for vesting of performance and restricted stock awards, net of shares retained for tax liability (5,603) $ 1 (5,604)      
Common stock issued for vesting of performance and restricted stock awards, net of shares retained for tax liability, shares   3,292        
Foreign currency translation adjustments (2,020)       (2,020)  
Net loss (33,906)         (33,906)
Balance at Mar. 31, 2026 (5,347) $ 16 1,484,529 (25,097) (6,446) (1,458,349)
Balance, shares at Mar. 31, 2026   153,794        
Balance at Dec. 31, 2025 12,426 $ 15 1,466,377 (25,097) (4,426) (1,424,443)
Balance, shares at Dec. 31, 2025   150,257        
Purchase of capped calls 0          
Foreign currency translation adjustments (2,248)          
Net loss (59,687)          
Balance at Jun. 30, 2026 (12,069) $ 16 1,503,816 (25,097) (6,674) (1,484,130)
Balance, shares at Jun. 30, 2026   154,491        
Balance at Mar. 31, 2026 (5,347) $ 16 1,484,529 (25,097) (6,446) (1,458,349)
Balance, shares at Mar. 31, 2026   153,794        
Stock-based compensation 18,147   18,147      
Common stock issued for employee stock purchase plan and stock option exercises 1,525   1,525      
Common stock issued for employee stock purchase plan and stock option exercises, shares   330        
Common stock issued for vesting of performance and restricted stock awards, net of shares retained for tax liability (385)   (385)      
Common stock issued for vesting of performance and restricted stock awards, net of shares retained for tax liability, shares   367        
Foreign currency translation adjustments (228)       (228)  
Net loss (25,781)         (25,781)
Balance at Jun. 30, 2026 $ (12,069) $ 16 $ 1,503,816 $ (25,097) $ (6,674) $ (1,484,130)
Balance, shares at Jun. 30, 2026   154,491